Multi-center surveillance for pneumonia & meningitis among children (<2 yr) for Hib vaccine probe trial preparation in India

Indian Journal of Medical Research

Volumn 131, Issue 5, 2010, Pages 649-658

  Gupta, Madhu ^a   Kumar, Rajesh ^a   Deb, Alok Kumar ^b   Bhattacharya, Sujit Kumar ^b   Bose, Anuradha ^c   John, Jacob ^c   Balraj, Vinohar ^c   Ganguly, N K ^d   Kant, Lalit ^d   Kapoor, Ambujam Nair ^d   Watt, James ^e   Shearer, Jessica ^e   Santosham, Mathuram ^e  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^c CHRISTIAN MEDICAL COLLEGE   (India)

^d INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Haemophilus influenzae type b; Incidence; India; Meningitis; Severe pneumonia

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ARTICLE; BACTERIUM DETECTION; BLOOD CULTURE; CELL COUNT; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID CYTOLOGY; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE SURVEILLANCE; EVIDENCE BASED MEDICINE; FEASIBILITY STUDY; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS MENINGITIS; HUMAN; IMMUNOSURVEILLANCE; INCIDENCE; INDIA; LATEX AGGLUTINATION TEST; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; NOSE SMEAR; PNEUMONIA; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRESCHOOL CHILD; PREVALENCE; THORAX RADIOGRAPHY; THROAT CULTURE;

BACTERIAL CAPSULES; CHILD, PRESCHOOL; FEASIBILITY STUDIES; HAEMOPHILUS VACCINES; HUMANS; INDIA; INFANT; MENINGITIS, BACTERIAL; PNEUMONIA, BACTERIAL; POPULATION SURVEILLANCE;

EID: 77952391474     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Wenger JD. Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada. Peadiatr Infect Dis J 1998; 17: S132-6.
2. Adegbola RA, Mulholland EK, Falade AG, Secka O, Sarge-Njai R, Corrah T, et al. Haemophilus influenzae type b disease in the Western Region of the Gambia: background surveillance for a vaccine efficacy trial. Ann Trop Paediatr 1996; 16: 103-11.
3. Yaro S, Lourd M, Naccro B, Njanpop-Lafourcade BM, Hien A, Ouedraogo MS. The epidemiology of Haemophilus influenzae type b meningitis in Burkina Faso. Peadiatr Infect Dis J 2006; 25: 415-9.
4. Campagne G, Garba A, Schuchat A, Boulanger D, Plikaytis B, Ousseini M, et al. Response to conjugate Haemophilus influenzae b vaccine among infants in Niamey, Niger. Am J Trop Med Hyg 1998; 59: 837-42.
5. Jordens JZ, Slack MPE. Haemophilus influenzae: Then and now. Eur J Clin Microbiol Infect Dis 1995; 14: 935-48.
6. Peltola H. Haemophilus influenzae type b disease and vaccination in Europe: lessons learnt. Peadiatr Infect Dis J 1998; 17: S126-32.
7. Salisbury DM. The introduction of Haemophilus influenzae type b immunization into the United Kingdom: practical steps to assure success. Peadiatr Infect Dis J 1998; 17: S136-9.
8. Adegbola RA, Secka O, Lahai G, Lloyd-Evans N, Njie A, Usen S, et al. Elimination of Haemophilus influenzae type b (Hib) disease from the Gambia after the introduction of routine immunization with a Hib conjugate vaccine: a prospective study. Lancet 2005; 366: 144-50.
9. Lewis R, Kisakye A, Gessner B, Duku C, Odipio J, Iriso R. Action for child survival: elimination of Haemophilus influenzae type b meningitis in Uganda. Bull World Health Organ 2008; 86: 292-301.
10. Invasive Bacterial Infections Surveillance (IBIS) Group 10. of the International Clinical Epidemiology Network. Are Haemophilus influenzae infections significant problems in India? A prospective study and review. Clin Infect Dis 2002; 34: 949-57.
11. Salisbury DM. Summary statement: The First International Conference on Haemophilus influenzae type b infection in Asia. Pediatr Infect Dis J 1998; 17: S93-5.
12. Levine OS, Schwartz B, Pierce N, Kane M. Development, evaluation and implementation of Haemophilus influenzae type b vaccines for young children in developing countries: current status and priority actions. Pediatr Infect Dis J 1998; 17: 95-113.
13. Mulholland K, Hilton S, Adegbola R, Usen S, Oparaugo A, Omosigho. Randomized trial of Heamophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants. Lancet 1997; 349: 1191-7.
14. Levine OS, Lagos R, Munoz A, Villaroel J, Alvarez AM, Abrego P, et al. Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b. Paediatr Infect Dis J 1999; 18: 1060-4.
15. de la Hoz F, Higuera AB, Di Fabio JL, Luna M, Naranjo AG, de la Luz Valencia M, et al. Effectiveness of Haemophilus influenzae type B vaccine against bacterial pneumonia in Colombia. Vaccine 2004; 23: 36-42.
16. de Andrade ALSS, de Andrade JG, Martelli CMT, e Silva SA, de Oliveira RM, Costa MSN, et al. Effectiveness of Haemophilus influenzae type b vaccine on childhood pneumonia: a case- control study in Brazil. Int J Epidemiol 2004; 33: 173-81.
17. Baqui AH, El Arifeen S, Saha SK, Persson L, Zaman K, Gessner BD, et al. Effectiveness of Haemophilus influenzae type B conjugate vaccine on prevention of pneumonia and meningitis in Bangladeshi children: a case-control study. Paediatr Infect Dis J 2007; 26: 565-71.
18. Gessner BD, Sutanto A, Linehan M, Djelntik GG, Gerudug K, Ingerani. Incidences of vaccine preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial. Lancet 2005; 365: 43-52.
19. WHO Position Paper on Haemophilus influenzae type b conjugate vaccines. Weekly Epidemiol Rec 2006; 47: 442-5.
20. World Health Organization Pneumonia Vaccine Trial Investigators' Group. Standardization of interpretation of chest radiographs for the diagnosis of pneumonia in children. Available at: http://www.who.int/vaccine_research/ documents/en/pneumonia_children.pdfref, accessed on April 10, 2008.
21. Campos J. Manual of clinical microbiology, 7th ed. Washington DC: American Society of Microbiology; 1999. p. 604-13.
22. Reidl J, Mekalanos JJ. Lipoprotein e (P4) is essential for hemin uptake by Haemophilus influenzae. J Exp Med 1996; 183: 621-9.
23. WHO/CHD Immunisation-Linked Vitamin A Supplementation Study Group. Randomised trial to assess benefits and safety of vitamin A supplementation linked to immunisation in early infancy. Lancet 1998; 352: 1257-63.
24. Shekher S, Chakarborti A, Kumar R. Haemophilus influenzae colonization and its risk factors among less than two year old children in Northern India. Epidemiol Infectn 2008 (in press).
25. Das BK, Arora NK, Mathur P, Ostwal P, Mandal S, Kabra SK, et al. Nasopharyngeal carriage of Haemophilus influenzae. Indian J Pediatr 2002; 69: 775-7.
26. Oguzkaya-Artan M, Baykan Z, Artan C. Carriage rate of Haemophilus influenzae among preschool children in Turkey. Jpn J Infect Dis 2007; 60: 179-82.
27. Olsen SJ, Dejsirilert S, Sangsuk L, Chunsutiwat S, Dowell SF. Frequent Haemophilus influenzae type B colonization in rural Thailand. Pediatr Infect Dis J 2005; 24: 739-42.
28. Tran TT, Le QT, Tran TN, et al. The etiology of bacterial pneumonia and meningitis in Vietnam. Pediatr Infect Dis J 1998; 17: S192-4.
29. Vuori-Holopainen E, Peltola H. Reappraisal of lung tap: review of an old method for better etiologic diagnosis of childhood pneumonia. Clin Infect Dis 2001; 32: 715-26.
30. Isaacs D. Problems in determining the etiology of community-acquired childhood pneumonia. Pediatr Infect Dis J 1989; 8: 143-8.
31. Kilpatrick ME, Mikhail IA, Girgis NI. Negative cultures of cerebrospinal fluid in partially treated bacterial meningitis. Trop Geogr Med 1987; 39: 345-9.
32. Watt JP, Wolfson LJ, O'Brien KL, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimate. Lancet 2009; 374: 903-11.